SoVarGen
Developer of novel therapeutics and diagnostics designed to treat intractable central nervous system (CNS) diseases caused by low-level somatic mutation. The company provides differentiated research a...
Valuation
$0
Share Price
N/A
Total Raised
$55.6M
Last Round
N/A